Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | TK1 | P04183 | 2/20 | 0.36 |
| ▸ | EDNRB | P24530 | 5/20 | 0.35 |
| ▸ | EDNRA | P25101 | 5/20 | 0.35 |
| ▸ | KIF11 | P52732 | 3/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.35 |
| ▸ | ELANE | P08246 | 1/20 | 0.34 |
| ▸ | DUT | P33316 | 1/20 | 0.34 |
| ▸ | GRIN2D | O15399 | 2/20 | 0.33 |
| ▸ | GRIN1 | Q05586 | 2/20 | 0.33 |
| ▸ | GRIN2A | Q12879 | 2/20 | 0.33 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.33 |
| ▸ | GRIN2C | Q14957 | 2/20 | 0.33 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CACNA1F | O60840 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2179039 | 0.81 | KMT2A (0.42) | KMT2ATK1KIF11GRIN2DGRIN1 | |
| SCHEMBL2180294 | 0.77 | TK1 (0.39) | KMT2ATK1KIF11CYP2C19HIF1A | |
| SCHEMBL9365537 | 0.76 | KIF11 (0.43) | KMT2ATK1KIF11CYP2C19HIF1A | |
| SCHEMBL9365526 | 0.76 | KIF11 (0.43) | KMT2ATK1KIF11CYP2C19HIF1A | |
| SCHEMBL4535864 | 0.74 | CYP2C19 (0.37) | KMT2ATK1KIF11CYP2C19HIF1A | |
| SCHEMBL12409617 | 0.74 | CYP2C19 (0.37) | KMT2ATK1KIF11CYP2C19HIF1A | |
| SCHEMBL2178034 | 0.74 | KIF11 (0.44) | KMT2ATK1KIF11CYP2C19ELANE | |
| SCHEMBL4525211 | 0.74 | KIF11 (0.44) | KMT2ATK1KIF11CYP2C19ELANE | |
| SCHEMBL4527231 | 0.73 | KIF11 (0.36) | KMT2ATK1KIF11CYP2C19HIF1A | |
| SCHEMBL2179966 | 0.72 | PRKCA (0.34) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110166163-A1 | SUBSTITUTED FUROPYRIMIDINES AND USE THEREOF | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2011-07-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110166163-A1 | SUBSTITUTED FUROPYRIMIDINES AND USE THEREOF | DPYD, TPMT, TYMP | KMT2A 1997/4885TK1 175/4885EDNRB 1522/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.